Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build Kenya flag

Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Background
... 3 Use Cases
... 4 Downloads
... 5 Artifacts Summary
.... 5.1 NCCP Body Surface Area Observation
.... 5.2 NCCP Cancer Suspicion Observation
.... 5.3 NCCP Chemotherapy Medication Request
.... 5.4 NCCP CTCAE Adverse Event Observation
.... 5.5 NCCP ECOG Performance Status Observation
.... 5.6 NCCP Morphology Observation
.... 5.7 NCCP Oncology Adverse Event
.... 5.8 NCCP Oncology Care Plan
.... 5.9 NCCP Oncology Care Team
.... 5.10 NCCP Oncology Claim
.... 5.11 NCCP Oncology Claim Response
.... 5.12 NCCP Oncology Coverage Eligibility Request
.... 5.13 NCCP Oncology Diagnosis Condition
.... 5.14 NCCP Oncology Diagnostic Report
.... 5.15 NCCP Oncology Diagnostic Service Request
.... 5.16 NCCP Oncology Encounter
.... 5.17 NCCP Oncology Episode of Care
.... 5.18 NCCP Oncology Medication Administration
.... 5.19 NCCP Oncology Plan Definition
.... 5.20 NCCP Oncology Referral Service Request
.... 5.21 NCCP Oncology Request Group
.... 5.22 NCCP Prior Bone Marrow Transplant Procedure
.... 5.23 NCCP Prior Radiotherapy Procedure
.... 5.24 NCCP Prior Surgery Procedure
.... 5.25 NCCP Prior Systemic Therapy Statement
.... 5.26 NCCP Radiotherapy Care Plan
.... 5.27 NCCP Radiotherapy Dose Observation
.... 5.28 NCCP Radiotherapy Plan Definition
.... 5.29 NCCP Radiotherapy Service Request
.... 5.30 NCCP Radiotherapy Treatment Procedure
.... 5.31 NCCP RECIST Baseline Observation
.... 5.32 NCCP RECIST New Lesion Observation
.... 5.33 NCCP RECIST Non-Target Lesion Observation
.... 5.34 NCCP RECIST Overall Response Assessment Observation
.... 5.35 NCCP RECIST Target Lesion Observation
.... 5.36 NCCP TNM Staging Observation
.... 5.37 Applies From Cycle Extension
.... 5.38 Applies To Cycle Extension
.... 5.39 BMT Type Extension
.... 5.40 BSA Based Dose Extension
.... 5.41 BSA Formula Extension
.... 5.42 Cancer Suspicion Level Extension
.... 5.43 Carcinoma Staging Extension
.... 5.44 Causative Medication Administration Extension
.... 5.45 Clinical Category Extension
.... 5.46 Coinsurance Details Extension
.... 5.47 Comorbidity Extension
.... 5.48 Cost Per Session Extension
.... 5.49 CTCAE Action Taken Extension
.... 5.50 CTCAE Attribution Extension
.... 5.51 CTCAE Grade Extension
.... 5.52 Cycle Day End Extension
.... 5.53 Cycle Day Start Extension
.... 5.54 Cycle Length Days Extension
.... 5.55 Cycle Number Extension
.... 5.56 Diagnosis Status Extension
.... 5.57 Dose Per Unit Extension
.... 5.58 End Cycle Extension
.... 5.59 Has Coinsurance Extension
.... 5.60 Metastases Sites Extension
.... 5.61 Parent Authorization Extension
.... 5.62 Planned Cycles Extension
.... 5.63 Post-Coordinated ICD-11 Code Extension
.... 5.64 Prior Treatment Outcome Extension
.... 5.65 Protocol Markers Extension
.... 5.66 Radiotherapy Beam Type Extension
.... 5.67 Radiotherapy Cumulative Dose Extension
.... 5.68 Radiotherapy Dose Per Fraction Extension
.... 5.69 Radiotherapy Fraction Number Extension
.... 5.70 Radiotherapy Intent Extension
.... 5.71 Radiotherapy Target Volume Extension
.... 5.72 Radiotherapy Total Fractions Extension
.... 5.73 Radiotherapy Treatment Machine Extension
.... 5.74 Radiotherapy Treatment Technique Extension
.... 5.75 Reason For Suspicion Extension
.... 5.76 RECIST Target Lesion ID Extension
.... 5.77 RECIST Timepoint Extension
.... 5.78 Referral Source Extension
.... 5.79 Regimen Code Extension
.... 5.80 Regimen Reference Extension
.... 5.81 Session Expected Date Extension
.... 5.82 Session ID Extension
.... 5.83 Session Number Extension
.... 5.84 Sessions Covered Extension
.... 5.85 Sessions Per Cycle Extension
.... 5.86 Sessions Required Extension
.... 5.87 Sessions Used Extension
.... 5.88 Start Cycle Extension
.... 5.89 Treatment Eligibility Extension
.... 5.90 Treatment Intent Extension
.... 5.91 Treatment Setting Extension
.... 5.92 Kenya Adverse Event Category Value Set
.... 5.93 Kenya BMT Type Value Set
.... 5.94 Kenya BSA Formula Value Set
.... 5.95 Kenya Cancer Grade Value Set
.... 5.96 Kenya Cancer Manifestation Codes Value Set
.... 5.97 Kenya Cancer Primary Site Value Set
.... 5.98 Kenya Cancer Stage Summary Value Set
.... 5.99 Kenya Cancer Stage Type Value Set
.... 5.100 Kenya Cancer Suspicion Level Value Set
.... 5.101 Kenya Care Plan Category Value Set
.... 5.102 Kenya Care Team Category Value Set
.... 5.103 Kenya Condition Category Value Set
.... 5.104 Kenya Condition Clinical Status Value Set
.... 5.105 Kenya Condition Severity Value Set
.... 5.106 Kenya Condition Verification Status Value Set
.... 5.107 Kenya CTCAE Action Taken Value Set
.... 5.108 Kenya CTCAE Adverse Event Terms Value Set
.... 5.109 Kenya CTCAE Attribution Value Set
.... 5.110 Kenya CTCAE Grade Value Set
.... 5.111 Kenya CTCAE Outcome Value Set
.... 5.112 Kenya Diagnostic Test Urgency Value Set
.... 5.113 Kenya Disease Extent Value Set
.... 5.114 Kenya ECOG Performance Status Value Set
.... 5.115 Kenya Episode of Care Status Value Set
.... 5.116 Kenya Episode of Care Type Value Set
.... 5.117 Kenya Generic Oncology Products Value Set
.... 5.118 Kenya ICD-11 Anatomy Value Set
.... 5.119 Kenya ICD-11 Disease Severity Value Set
.... 5.120 Kenya Laterality Value Set
.... 5.121 Kenya Manifestation Or Symptom Value Set
.... 5.122 Kenya Medication Administration Route Value Set
.... 5.123 Kenya Medication Administration Status Reason Value Set
.... 5.124 Kenya Medication Clinical Category Value Set
.... 5.125 Kenya MedicationRequest Status Reason Value Set
.... 5.126 Kenya Metastases Sites Value Set
.... 5.127 Kenya Morphology Codes Value Set
.... 5.128 Kenya Morphology Method Value Set
.... 5.129 Kenya OCM Protocol Markers Value Set
.... 5.130 Kenya Oncology Condition Codes Value Set
.... 5.131 Kenya Oncology Diagnosis Status Value Set
.... 5.132 Kenya Oncology Encounter Status Value Set
.... 5.133 Kenya Oncology Encounter Type Value Set
.... 5.134 Kenya Oncology Practitioner Roles Value Set
.... 5.135 Kenya Oncology Unit of Measure Value Set
.... 5.136 Kenya Plan Definition Type Value Set
.... 5.137 Kenya PPB Route of Administration Value Set
.... 5.138 Kenya Prior Treatment Outcome Value Set
.... 5.139 Kenya Procedure Code Value Set
.... 5.140 Kenya Radiotherapy Beam Type Value Set
.... 5.141 Kenya Radiotherapy Intent Value Set
.... 5.142 Kenya Radiotherapy Target Volume Value Set
.... 5.143 Kenya Radiotherapy Treatment Technique Value Set
.... 5.144 Kenya Reason For Suspicion Value Set
.... 5.145 Kenya RECIST Assessment Timepoint Value Set
.... 5.146 Kenya RECIST Response Value Set
.... 5.147 Kenya Referral Source Value Set
.... 5.148 Kenya SHA Oncology Interventions Value Set
.... 5.149 Kenya TNM Clinical M Value Set
.... 5.150 Kenya TNM Clinical N Value Set
.... 5.151 Kenya TNM Clinical T Value Set
.... 5.152 Kenya Treatment Course (Regimen) Value Set
.... 5.153 Kenya Treatment Intent Value Set
.... 5.154 Kenya Treatment Setting Value Set
.... 5.155 Kenya Adverse Event Category Code System
.... 5.156 Kenya Bone Marrow / Stem Cell Transplant Type Code System
.... 5.157 Kenya BSA Formula Code System
.... 5.158 Kenya Cancer Grade Code System
.... 5.159 Kenya Cancer Manifestation Codes Code System
.... 5.160 Kenya Cancer Primary Site Code System
.... 5.161 Kenya Cancer Stage Summary Code System
.... 5.162 Kenya Cancer Stage Type Code System
.... 5.163 Kenya Cancer Suspicion Level Code System
.... 5.164 Kenya Care Plan Category Code System
.... 5.165 Kenya Care Team Category Code System
.... 5.166 Kenya Clinical M Stage Code System
.... 5.167 Kenya Clinical N Stage Code System
.... 5.168 Kenya Clinical T Stage Code System
.... 5.169 Kenya Condition Category Code System
.... 5.170 Kenya Condition Clinical Status Code System
.... 5.171 Kenya Condition Severity Code System
.... 5.172 Kenya Condition Verification Status Code System
.... 5.173 Kenya CTCAE Action Taken Code System
.... 5.174 Kenya CTCAE Adverse Event Terms Code System
.... 5.175 Kenya CTCAE Attribution Code System
.... 5.176 Kenya CTCAE Grade Code System
.... 5.177 Kenya CTCAE Outcome Code System
.... 5.178 Kenya Diagnostic Test Urgency Code System
.... 5.179 Kenya Disease Extent Code System
.... 5.180 Kenya ECOG Performance Status Code System
.... 5.181 Kenya Episode of Care Status Code System
.... 5.182 Kenya Episode of Care Type Code System
.... 5.183 Kenya Generic Oncology Products Code System
.... 5.184 Kenya ICD-11 Anatomy Code System
.... 5.185 Kenya ICD-11 Disease Severity Code System
.... 5.186 Kenya Laterality Code System
.... 5.187 Kenya Manifestation Or Symptom Code System
.... 5.188 Kenya Medication Administration Route Code System
.... 5.189 Kenya Medication Administration Status Reason Code System
.... 5.190 Kenya Medication Clinical Category Code System
.... 5.191 Kenya MedicationRequest Status Reason Code System
.... 5.192 Kenya Metastases Sites Code System
.... 5.193 Kenya Morphology Codes Code System
.... 5.194 Kenya Morphology Method Code System
.... 5.195 Kenya OCM Protocol Markers Code System
.... 5.196 Kenya Oncology Condition (ICD-10) Code System
.... 5.197 Kenya Oncology Diagnosis Status Code System
.... 5.198 Kenya Oncology Encounter Status Code System
.... 5.199 Kenya Oncology Encounter Type Code System
.... 5.200 Kenya Oncology Practitioner Roles Code System
.... 5.201 Kenya Oncology Unit of Measure Code System
.... 5.202 Kenya Plan Definition Type Code System
.... 5.203 Kenya PPB Route of Administration Code System
.... 5.204 Kenya Prior Treatment Outcome Code System
.... 5.205 Kenya Procedure Code Code System
.... 5.206 Kenya Radiotherapy Beam Type Code System
.... 5.207 Kenya Radiotherapy Intent Code System
.... 5.208 Kenya Radiotherapy Target Volume Code System
.... 5.209 Kenya Radiotherapy Treatment Technique Code System
.... 5.210 Kenya Reason For Suspicion Code System
.... 5.211 Kenya RECIST Assessment Timepoint Code System
.... 5.212 Kenya RECIST Response Code System
.... 5.213 Kenya Referral Source Code System
.... 5.214 Kenya SHA Oncology Interventions Code System
.... 5.215 Kenya Treatment Course (Regimen) Code System
.... 5.216 Kenya Treatment Intent Code System
.... 5.217 Kenya Treatment Setting Code System
.... 5.218 Kenya NCCP Diagnostic Service Request Identifier
.... 5.219 Kenya NCCP Episode of Care Identifier
.... 5.220 Kenya NCCP Medication Request Identifier
.... 5.221 Kenya NCCP Oncology Care Plan Identifier
.... 5.222 Kenya NCCP Oncology Encounter Identifier
.... 5.223 Kenya NCCP Radiotherapy Care Plan Identifier
.... 5.224 Kenya NCCP Regimen / Plan Definition Identifier
.... 5.225 Kenya NCCP Treatment Session Request Group Identifier
.... 5.226 Example Body Surface Area Observation — 1.75 m²
.... 5.227 Example Cancer Suspicion Observation — High Suspicion Cervical Cancer
.... 5.228 Example Care Plan (Stub)
.... 5.229 Example Care Team (Stub)
.... 5.230 Example Chemotherapy Medication Request — Doxorubicin
.... 5.231 Example Condition (Stub)
.... 5.232 Example Coverage (Stub)
.... 5.233 Example Coverage Eligibility Request — SHA Chemotherapy Pre-authorisation
.... 5.234 Example CTCAE Adverse Event Observation — Grade 2 Nausea
.... 5.235 Example Diagnostic Report — Cervical Biopsy Histopathology
.... 5.236 Example Diagnostic Service Request — Colposcopy-directed Biopsy
.... 5.237 Example Diagnostic ServiceRequest (Stub)
.... 5.238 Example ECOG Performance Status Observation — ECOG 1
.... 5.239 Example Encounter (Stub)
.... 5.240 Example Episode of Care (Stub)
.... 5.241 Example Medication Administration — Doxorubicin Cycle 1 Day 1
.... 5.242 Example MedicationAdministration (Stub)
.... 5.243 Example MedicationRequest — Doxorubicin (Stub)
.... 5.244 Example Morphology Observation — Invasive Ductal Carcinoma
.... 5.245 Example NCCP Oncology Care Plan (AC-T Chemotherapy)
.... 5.246 Example NCCP Oncology Diagnosis — Invasive Ductal Carcinoma
.... 5.247 Example Oncology Adverse Event — Grade 3 Febrile Neutropenia
.... 5.248 Example Oncology Care Team — Breast Cancer MDT
.... 5.249 Example Oncology Claim (Stub)
.... 5.250 Example Oncology Claim Response — SHA Pre-authorisation Approved
.... 5.251 Example Oncology Claim — AC Chemotherapy Cycle 1 Session 1
.... 5.252 Example Oncology Encounter — Chemotherapy Treatment Session
.... 5.253 Example Oncology Episode of Care — Breast Cancer
.... 5.254 Example Oncology Plan Definition — AC-T Regimen Template
.... 5.255 Example Oncology Referral — From County Hospital to National Cancer Centre
.... 5.256 Example Oncology Request Group — Cycle 1 Session 1 (AC)
.... 5.257 Example Organization (Stub)
.... 5.258 Example Patient (Stub)
.... 5.259 Example Practitioner (Stub)
.... 5.260 Example Prior BMT Procedure — Autologous Stem Cell Transplant for Myeloma
.... 5.261 Example Prior Radiotherapy Procedure — Cervical Cancer RT
.... 5.262 Example Prior Surgery Procedure — Left Breast Wide Local Excision
.... 5.263 Example Prior Systemic Therapy Statement — Tamoxifen Adjuvant Hormonal Therapy
.... 5.264 Example Radiation Therapist (Stub)
.... 5.265 Example Radiotherapy Care Plan — Adjuvant Breast RT
.... 5.266 Example Radiotherapy Dose Observation — End-of-Treatment Summary
.... 5.267 Example Radiotherapy Plan Definition — Whole Breast 3DCRT Protocol
.... 5.268 Example Radiotherapy Service Request — Adjuvant Whole Breast RT
.... 5.269 Example Radiotherapy Treatment Procedure — Fraction 1 of 25
.... 5.270 Example RECIST Baseline Observation — Sum of Target Lesion Diameters
.... 5.271 Example RECIST New Lesion Observation — No New Lesions at Week 8
.... 5.272 Example RECIST Non-Target Lesion Observation — Liver Metastasis at Week 8
.... 5.273 Example RECIST Overall Response Assessment — Partial Response
.... 5.274 Example RECIST Target Lesion Observation — Left Axillary Node Week 8
.... 5.275 Example RT Care Plan (Stub)
.... 5.276 Example Target Lesion Observation (Stub)
.... 5.277 Example TNM Staging Observation — Breast Cancer Stage IIB
.... 5.278 KNH Oncology (Stub)
.... 5.279 Oncology Day Unit (Stub)
.... 5.280 SHA Kenya (Stub)